Annual EBITDA
$1.09B$194.00M-15.17%
Summary
- Current Value
- As of today, HOLX annual EBITDA is $1.09B, down -15.17% on
- Historical Performance
- HOLX annual EBITDA is down -47.78% over the past 3 years, down -28.91% over the past 5 years
- All-Time High Comparison
- HOLX annual EBITDA is currently -62.45% below its historical high of $2.89B set on
- 3-Year Low Comparison
- HOLX annual EBITDA is at its 3-year low
- Sector Comparison
- HOLX annual EBITDA is higher than 94.78% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.09B | -15.2% | -47.8% | -28.9% | +80.9% | |
| Quarterly EBITDA | $310.50M | +0.9% | -11.1% | -68.5% | +111.5% | |
| TTM EBITDA | $1.26B | -0.8% | -24.6% | -44.2% | +110.2% | |
| Price | $74.91 | +17.8% | -10.2% | -9.7% | +271.2% | |
| PE Ratio | 31.08 | +54.4% | +46.0% | +97.5% | – | |
| Annual Revenue | $4.10B | +1.7% | -15.7% | +8.6% | +144.1% | |
| Annual EPS | $2.49 | -25.2% | -51.5% | -41.0% | +1123.8% | |
| $785.40M | -19.1% | -52.4% | -31.7% | +157.4% | ||
| Annual Net Income | $565.70M | -28.4% | -56.5% | -49.1% | +1000.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.08B | N/A | -47.8% |
| 5Y | $2.89B | -62.5% | |
| All | $2.89B | -62.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.09B | at low | |
| 5Y | $1.09B | at low | |
| All | -$22.94M | +4830.8% |
EBITDA History
FAQ
What is the current annual EBITDA of HOLX?
As of today, HOLX annual EBITDA is $1.09B
What is 1-year change in HOLX annual EBITDA?
HOLX annual EBITDA is down -15.17% year-over-year
What is 3-year change in HOLX annual EBITDA?
HOLX annual EBITDA is down -47.78% over the past 3 years
How far is HOLX annual EBITDA from its all-time high?
HOLX annual EBITDA is currently -62.45% below its historical high of $2.89B set on September 25, 2021
How does HOLX annual EBITDA rank versus sector peers?
HOLX annual EBITDA is higher than 94.78% of companies in Healthcare sector
When is HOLX next annual earnings release?
As of today, the next annual earnings release for HOLX has not been scheduled
Quarterly EBITDA
$310.50M$12.20M-3.78%
Summary
- Current Value
- As of today, HOLX quarterly EBITDA is $310.50M, down -3.78% on
- Historical Performance
- HOLX quarterly EBITDA is up +0.91% year-over-year, down -11.13% over the past 3 years
- All-Time High Comparison
- HOLX quarterly EBITDA is currently -68.45% below its historical high of $984.30M set on
- 3-Year Low Comparison
- HOLX quarterly EBITDA is +17.48% above its 3-year low of $264.30M reached on
- Sector Comparison
- HOLX quarterly EBITDA is higher than 94.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $310.50M | -3.8% | +0.9% | -11.1% | -68.5% | |
| Annual EBITDA | $1.09B | – | -15.2% | -47.8% | -28.9% | |
| TTM EBITDA | $1.26B | +0.2% | -0.8% | -24.6% | -44.2% | |
| Price | $74.91 | +0.9% | +17.8% | -10.2% | -9.7% | |
| PE Ratio | 31.08 | +3.9% | +54.4% | +46.0% | +97.5% | |
| Quarterly Revenue | $1.05B | -0.2% | +2.5% | -2.5% | -34.9% | |
| Quarterly EPS | $0.79 | -4.5% | -8.4% | +5.5% | -68.3% | |
| $240.90M | -4.8% | +3.1% | -8.6% | -73.0% | ||
| Quarterly Net Income | $179.10M | -4.4% | -10.9% | -4.4% | -72.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $331.10M | -6.2% | |
| 3Y | $349.40M | N/A | -11.1% |
| 5Y | $984.30M | N/A | -68.5% |
| All | $984.30M | -68.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $297.40M | +4.4% | |
| 3Y | $264.30M | +17.5% | |
| 5Y | $264.30M | +17.5% | |
| All | -$12.40M | +2604.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HOLX?
As of today, HOLX quarterly EBITDA is $310.50M
What is HOLX quarterly EBITDA most recent change?
HOLX quarterly EBITDA was down -3.78% on December 27, 2025
What is 1-year change in HOLX quarterly EBITDA?
HOLX quarterly EBITDA is up +0.91% year-over-year
How far is HOLX quarterly EBITDA from its all-time high?
HOLX quarterly EBITDA is currently -68.45% below its historical high of $984.30M set on December 26, 2020
How does HOLX quarterly EBITDA rank versus sector peers?
HOLX quarterly EBITDA is higher than 94.32% of companies in Healthcare sector
When is HOLX next earnings release?
The next earnings release for HOLX is on
TTM EBITDA
$1.26B$2.80M+0.22%
Summary
- Current Value
- As of today, HOLX TTM EBITDA is $1.26B, up +0.22% on
- Historical Performance
- HOLX TTM EBITDA is down -0.79% year-over-year, down -24.59% over the past 3 years
- All-Time High Comparison
- HOLX TTM EBITDA is currently -58.82% below its historical high of $3.06B set on
- 3-Year Low Comparison
- HOLX TTM EBITDA is +4.72% above its 3-year low of $1.20B reached on
- Sector Comparison
- HOLX TTM EBITDA is higher than 95.14% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.26B | +0.2% | -0.8% | -24.6% | -44.2% | |
| Annual EBITDA | $1.09B | – | -15.2% | -47.8% | -28.9% | |
| Quarterly EBITDA | $310.50M | -3.8% | +0.9% | -11.1% | -68.5% | |
| Price | $74.91 | +0.9% | +17.8% | -10.2% | -9.7% | |
| PE Ratio | 31.08 | +3.9% | +54.4% | +46.0% | +97.5% | |
| TTM Revenue | $4.13B | +0.6% | +2.2% | -7.6% | -9.0% | |
| TTM EPS | $2.41 | -2.9% | -23.8% | -38.5% | -54.3% | |
| $976.10M | +0.7% | -0.1% | -22.8% | -48.3% | ||
| TTM Net Income | $543.90M | -3.9% | -26.9% | -45.1% | -60.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.27B | N/A | -0.8% |
| 3Y | $1.67B | N/A | -24.6% |
| 5Y | $3.06B | -58.8% | |
| All | $3.06B | -58.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | +1.2% | |
| 3Y | $1.20B | +4.7% | |
| 5Y | $1.20B | +4.7% | |
| All | -$24.55M | +5239.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HOLX?
As of today, HOLX TTM EBITDA is $1.26B
What is HOLX TTM EBITDA most recent change?
HOLX TTM EBITDA was up +0.22% on December 27, 2025
What is 1-year change in HOLX TTM EBITDA?
HOLX TTM EBITDA is down -0.79% year-over-year
How far is HOLX TTM EBITDA from its all-time high?
HOLX TTM EBITDA is currently -58.82% below its historical high of $3.06B set on June 26, 2021
How does HOLX TTM EBITDA rank versus sector peers?
HOLX TTM EBITDA is higher than 95.14% of companies in Healthcare sector
When is HOLX next earnings release?
The next earnings release for HOLX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- HOLX Official Website www.hologic.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/859737/000085973726000008/0000859737-26-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/859737/000085973725000072/0000859737-25-000072-index.htm
- HOLX Profile on Yahoo Finance finance.yahoo.com/quote/HOLX
- HOLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/holx